KDR and stroke disorder: For this, we administered i.c.v. 13 nmoles of SU1498, a selective VEGFR2 inhibitor (Strawn et al., 1996), 30 min after the beginning of reperfusion and analyzed the overall effects of this procedure 24 h after stroke.